New Directions in Chronic Myelogenous Leukemia

This information was originally presented on March 17, 2012, at the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ held in Hollywood, Florida.
 
The goal of this activity is to provide participants with increased knowledge regarding the treatment of patients with chronic myelogenous leukemia (CML).

Target Audience

This activity is designed to meet the educational needs of oncologists, nurses, pharmacists, and other healthcare professionals who manage patients with CML.

Learning Objectives

Following this activity, participants should be able to:

  • Describe the current treatment options approved for the management of patients with CML
  • Identify the rationale and need for the development of more effective treatment options both in the first-line and second-line setting for patients with CML
  • Review the clinical evidence from ongoing trials evaluating novel treatment options and the potential role of new agents in treatment of CML
Additional information
Supporters: 

No commercial support was provided for this educational activity.

Course summary
Available credit: 
  • 0.75 Participation
  • 0.85 Nurse
  • 0.75 Pharmacist
  • 0.75 Physician
Course opens: 
07/13/2012
Course expires: 
03/01/2013
Cost:
$0.00

Javier Pinilla-Ibarz, MD, PhD
Moffitt Cancer Center

Available Credit

  • 0.75 Participation
  • 0.85 Nurse
  • 0.75 Pharmacist
  • 0.75 Physician

Accreditation Period

Course opens: 
07/13/2012
Course expires: 
03/01/2013

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

In order to view this activity, you will need to have sound playback capabilities and the latest version of Adobe Flash Player installed on your system. Some corporate firewalls may block streaming media traffic. Please be sure you are capable of receiving streaming Flash media (RTMP) traffic.